CY1116792T1 - Επιτοποι των il-17a και il-17f και αντισωματα ειδικα εναντι αυτων - Google Patents
Επιτοποι των il-17a και il-17f και αντισωματα ειδικα εναντι αυτωνInfo
- Publication number
- CY1116792T1 CY1116792T1 CY20151100929T CY151100929T CY1116792T1 CY 1116792 T1 CY1116792 T1 CY 1116792T1 CY 20151100929 T CY20151100929 T CY 20151100929T CY 151100929 T CY151100929 T CY 151100929T CY 1116792 T1 CY1116792 T1 CY 1116792T1
- Authority
- CY
- Cyprus
- Prior art keywords
- sites
- specifications against
- specifications
- relates
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/54—F(ab')2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Η παρούσα εφεύρεση αναφέρεται σε επιτόπους εξουδετέρωσης της IL-17A και της IL-17F και σε αντισώματα τα οποία προσδένονται σε αυτούς τους επιτόπους. Η παρούσα εφεύρεση αναφέρεται επίσης στις θεραπευτικές χρήσεις των μορίων των αντισωμάτων και σε μεθόδους παραγωγής τους.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0807413.0A GB0807413D0 (en) | 2008-04-23 | 2008-04-23 | Biological products |
EP09735498.9A EP2294083B1 (en) | 2008-04-23 | 2009-04-22 | Epitopes of il-17a and il-17f and antibodies specific thereto |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1116792T1 true CY1116792T1 (el) | 2017-03-15 |
Family
ID=39494115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20151100929T CY1116792T1 (el) | 2008-04-23 | 2015-10-19 | Επιτοποι των il-17a και il-17f και αντισωματα ειδικα εναντι αυτων |
Country Status (13)
Country | Link |
---|---|
US (4) | US8679494B2 (el) |
EP (2) | EP2975048A3 (el) |
CY (1) | CY1116792T1 (el) |
DK (1) | DK2294083T3 (el) |
ES (1) | ES2548452T3 (el) |
GB (1) | GB0807413D0 (el) |
HR (1) | HRP20151096T1 (el) |
HU (1) | HUE026003T2 (el) |
PL (1) | PL2294083T3 (el) |
PT (1) | PT2294083E (el) |
RS (1) | RS54302B1 (el) |
SI (1) | SI2294083T1 (el) |
WO (1) | WO2009130459A2 (el) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0620729D0 (en) | 2006-10-18 | 2006-11-29 | Ucb Sa | Biological products |
GB0807413D0 (en) * | 2008-04-23 | 2008-05-28 | Ucb Pharma Sa | Biological products |
CA2721713C (en) | 2008-05-05 | 2019-07-09 | Novimmune Sa | Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof |
EP2427203B1 (en) * | 2009-05-05 | 2018-10-17 | Novimmune S.A. | Anti-il-17f antibodies and use thereof |
AU2010313304B2 (en) * | 2009-10-30 | 2015-08-20 | Janssen Biotech, Inc. | IL-17A antagonists |
EA037071B1 (ru) * | 2011-01-14 | 2021-02-02 | Юсб Байофарма Срл | Молекулы антител, которые связываются с il-17a и il-17f |
AU2013206789B2 (en) * | 2011-12-28 | 2017-04-13 | Immunoqure Ag | Method of isolating human antibodies |
US10131709B2 (en) | 2011-12-28 | 2018-11-20 | Immunoqure Ag | Nucleic acid molecules encoding monoclonal antibodies specific for IL-22 |
GB201310544D0 (en) | 2013-06-13 | 2013-07-31 | Ucb Pharma Sa | Obtaining an improved therapeutic ligand |
TWI713453B (zh) | 2014-06-23 | 2020-12-21 | 美商健生生物科技公司 | 干擾素α及ω抗體拮抗劑 |
SG11201802887PA (en) | 2015-10-27 | 2018-05-30 | Ucb Biopharma Sprl | Methods of treatment using anti-il-17a/f antibodies |
US10858427B2 (en) | 2017-03-10 | 2020-12-08 | Suzhou Kanova Biopharmaceutical Co., Ltd. | Monoclonal antibody against both IL-17A and IL-17F and use of the same |
CN114380906B (zh) * | 2022-03-25 | 2022-06-14 | 南京融捷康生物科技有限公司 | 一种抗il-17a的单域抗体及其用途 |
IT202200016722A1 (it) * | 2022-08-04 | 2024-02-04 | Paolo Grieco | Nuovo peptide derivato da interleuchina-17A (IL-17A) e anticorpo neutralizzante (Ab17-IPL-1) |
Family Cites Families (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4741900A (en) | 1982-11-16 | 1988-05-03 | Cytogen Corporation | Antibody-metal ion complexes |
GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
DK336987D0 (da) | 1987-07-01 | 1987-07-01 | Novo Industri As | Immobiliseringsmetode |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
GB8719042D0 (en) | 1987-08-12 | 1987-09-16 | Parker D | Conjugate compounds |
GB8720833D0 (en) | 1987-09-04 | 1987-10-14 | Celltech Ltd | Recombinant dna product |
DE768377T1 (de) | 1988-09-02 | 1998-01-02 | Dyax Corp | Herstellung und Auswahl von Rekombinantproteinen mit verschiedenen Bindestellen |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
GB8907617D0 (en) | 1989-04-05 | 1989-05-17 | Celltech Ltd | Drug delivery system |
GB8928874D0 (en) | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
AU7247191A (en) | 1990-01-11 | 1991-08-05 | Molecular Affinities Corporation | Production of antibodies using gene libraries |
US5780225A (en) | 1990-01-12 | 1998-07-14 | Stratagene | Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules |
EP1690935A3 (en) | 1990-01-12 | 2008-07-30 | Abgenix, Inc. | Generation of xenogeneic antibodies |
US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
WO1992002551A1 (en) | 1990-08-02 | 1992-02-20 | B.R. Centre Limited | Methods for the production of proteins with a desired function |
US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
KR100272077B1 (ko) | 1990-08-29 | 2000-11-15 | 젠팜인터내셔날,인코포레이티드 | 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물 |
US5770429A (en) | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
US5698426A (en) | 1990-09-28 | 1997-12-16 | Ixsys, Incorporated | Surface expression libraries of heteromeric receptors |
ATE164395T1 (de) | 1990-12-03 | 1998-04-15 | Genentech Inc | Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften |
PT100379B (pt) | 1991-04-10 | 1999-01-29 | Scripps Research Inst | Bibliotecas de receptores heterodimericos usando fagomideos |
GB9112536D0 (en) | 1991-06-11 | 1991-07-31 | Celltech Ltd | Chemical compounds |
GB9113120D0 (en) | 1991-06-18 | 1991-08-07 | Kodak Ltd | Photographic processing apparatus |
GB9120467D0 (en) | 1991-09-26 | 1991-11-06 | Celltech Ltd | Anti-hmfg antibodies and process for their production |
WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
PT1024191E (pt) | 1991-12-02 | 2008-12-22 | Medical Res Council | Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos |
US5733743A (en) | 1992-03-24 | 1998-03-31 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
WO1995015982A2 (en) | 1993-12-08 | 1995-06-15 | Genzyme Corporation | Process for generating specific antibodies |
PT744958E (pt) | 1994-01-31 | 2003-11-28 | Univ Boston | Bancos de anticorpos policlonais |
FR2716640B1 (fr) | 1994-02-28 | 1996-05-03 | Procedes Machines Speciales | Dispositif de centrage et de blocage d'une pièce en vue de son rodage à l'aide d'un rodoir à expansion. |
US5516637A (en) | 1994-06-10 | 1996-05-14 | Dade International Inc. | Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage |
JP2978435B2 (ja) | 1996-01-24 | 1999-11-15 | チッソ株式会社 | アクリロキシプロピルシランの製造方法 |
US5980898A (en) | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
GB9625640D0 (en) | 1996-12-10 | 1997-01-29 | Celltech Therapeutics Ltd | Biological products |
EP1053751A1 (en) | 1999-05-17 | 2000-11-22 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Compositions and methods for treating cell proliferation disorders |
US20070160576A1 (en) * | 2001-06-05 | 2007-07-12 | Genentech, Inc. | IL-17A/F heterologous polypeptides and therapeutic uses thereof |
US6908963B2 (en) | 2001-10-09 | 2005-06-21 | Nektar Therapeutics Al, Corporation | Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith |
WO2004016377A2 (en) | 2002-08-16 | 2004-02-26 | Allied Machine & Engineering Corp. | Drilling tool and method for producing port seals |
PT1570267E (pt) | 2002-12-03 | 2012-01-03 | Ucb Pharma Sa | Ensaio para a identificação de células produtoras de anticorpos |
GB0303337D0 (en) | 2003-02-13 | 2003-03-19 | Celltech R&D Ltd | Biological products |
GB0312481D0 (en) | 2003-05-30 | 2003-07-09 | Celltech R&D Ltd | Antibodies |
GB0315450D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
GB0315457D0 (en) | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
SI1644412T2 (sl) | 2003-07-01 | 2018-11-30 | Ucb Biopharma Sprl | Modificirani fab fragmenti protiteles |
AU2004259638C1 (en) | 2003-07-08 | 2018-12-20 | Novartis Pharma Ag | IL-17 A/F heterologous polypeptides and therapeutic uses thereof |
EP1983000B1 (en) * | 2003-11-21 | 2015-09-02 | UCB Biopharma SPRL | Method for the treatment of multiple sclerosis by inhibiting IL-17 activity |
GB0411186D0 (en) | 2004-05-19 | 2004-06-23 | Celltech R&D Ltd | Biological products |
GB0412181D0 (en) | 2004-06-01 | 2004-06-30 | Celltech R&D Ltd | Biological products |
GB0417487D0 (en) * | 2004-08-05 | 2004-09-08 | Novartis Ag | Organic compound |
GB0425569D0 (en) | 2004-11-19 | 2004-12-22 | Celltech R&D Ltd | Biological products |
AP2007004034A0 (en) | 2004-12-31 | 2007-06-30 | Genentech Inc | Polypeptides sthat bind br3 and uses thereof |
PE20061391A1 (es) | 2005-02-14 | 2007-01-09 | Wyeth Corp | Anticuerpos para interleucina-17f y otros antagonistas de la senalizacion de il-17f |
RS57255B1 (sr) * | 2005-12-13 | 2018-08-31 | Lilly Co Eli | Anti-il-17 antitela |
EP1996622A2 (en) | 2006-03-10 | 2008-12-03 | Zymogenetics, Inc. | Antibodies that bind both il-17a and il-17f and methods of using the same |
TW200815469A (en) | 2006-06-23 | 2008-04-01 | Astrazeneca Ab | Compounds |
GB0612928D0 (en) | 2006-06-29 | 2006-08-09 | Ucb Sa | Biological products |
PE20080739A1 (es) * | 2006-08-11 | 2008-06-14 | Schering Corp | Anticuerpos para il-17a |
GB0620729D0 (en) * | 2006-10-18 | 2006-11-29 | Ucb Sa | Biological products |
GB0807413D0 (en) * | 2008-04-23 | 2008-05-28 | Ucb Pharma Sa | Biological products |
EA037071B1 (ru) * | 2011-01-14 | 2021-02-02 | Юсб Байофарма Срл | Молекулы антител, которые связываются с il-17a и il-17f |
-
2008
- 2008-04-23 GB GBGB0807413.0A patent/GB0807413D0/en not_active Ceased
-
2009
- 2009-04-22 WO PCT/GB2009/001026 patent/WO2009130459A2/en active Application Filing
- 2009-04-22 RS RS20150657A patent/RS54302B1/en unknown
- 2009-04-22 ES ES09735498.9T patent/ES2548452T3/es active Active
- 2009-04-22 DK DK09735498.9T patent/DK2294083T3/en active
- 2009-04-22 EP EP15178632.4A patent/EP2975048A3/en not_active Ceased
- 2009-04-22 US US12/989,373 patent/US8679494B2/en active Active
- 2009-04-22 HU HUE09735498A patent/HUE026003T2/en unknown
- 2009-04-22 EP EP09735498.9A patent/EP2294083B1/en active Active
- 2009-04-22 SI SI200931287T patent/SI2294083T1/sl unknown
- 2009-04-22 PT PT97354989T patent/PT2294083E/pt unknown
- 2009-04-22 PL PL09735498T patent/PL2294083T3/pl unknown
-
2014
- 2014-02-05 US US14/173,613 patent/US9045537B2/en active Active
-
2015
- 2015-06-29 US US14/695,677 patent/US9771420B2/en active Active
- 2015-10-19 HR HRP20151096TT patent/HRP20151096T1/hr unknown
- 2015-10-19 CY CY20151100929T patent/CY1116792T1/el unknown
-
2017
- 2017-09-07 US US15/698,082 patent/US20180037646A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2294083A2 (en) | 2011-03-16 |
HRP20151096T1 (en) | 2015-11-20 |
US20180037646A1 (en) | 2018-02-08 |
PL2294083T3 (pl) | 2015-12-31 |
ES2548452T3 (es) | 2015-10-16 |
EP2975048A3 (en) | 2016-05-11 |
US8679494B2 (en) | 2014-03-25 |
HUE026003T2 (en) | 2016-05-30 |
PT2294083E (pt) | 2015-11-02 |
US9045537B2 (en) | 2015-06-02 |
US20110262443A1 (en) | 2011-10-27 |
EP2294083B1 (en) | 2015-07-29 |
RS54302B1 (en) | 2016-02-29 |
SI2294083T1 (sl) | 2015-11-30 |
WO2009130459A2 (en) | 2009-10-29 |
EP2975048A2 (en) | 2016-01-20 |
WO2009130459A3 (en) | 2010-11-18 |
US9771420B2 (en) | 2017-09-26 |
US20150315272A1 (en) | 2015-11-05 |
GB0807413D0 (en) | 2008-05-28 |
DK2294083T3 (en) | 2015-09-14 |
US20140193403A1 (en) | 2014-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1116792T1 (el) | Επιτοποι των il-17a και il-17f και αντισωματα ειδικα εναντι αυτων | |
CY1121672T1 (el) | Αντισωματα που προσδενουν τα il-17a και il-17f | |
CY1121431T1 (el) | Μορια αντισωματος που εχουν ειδικοτητα για τον ανθρωπινο οχ40 | |
CY1122073T1 (el) | Μορια αντισωματος που εχουν εξειδικευση για τον ανθρωπινο οχ40 | |
CY1119055T1 (el) | Αντισωματα που προσδενονται στην il-17a και στην il-17f | |
CY1125133T1 (el) | Πρωτεϊνες συνδεσης αντιγονου υποδοχεα a il-17 | |
CY1121862T1 (el) | Αντισωματα anti-phf-tau και χρησεις αυτων | |
CY1121802T1 (el) | Μεθοδοι αγωγης της αγκυλοποιητικης σπονδυλιτιδας με τη χρηση αντισωματων anti-il-17 | |
CY1119994T1 (el) | Συνθεσεις και μεθοδοι για αυξηση της μυϊκης μαζας και της μυϊκης δυναμης ανταγωνιζοντας ειδικα ton gdf8 και/ή την ακτιβινη α | |
CY1124691T1 (el) | Διειδικα αντισωματα ειδικα για pd1 και τιμ3 | |
CY1119641T1 (el) | Μεθοδοι κατασκευης ανοσοσφαιρινων | |
CY1119173T1 (el) | Νεα μορια αναστολεα jnk | |
CY1117563T1 (el) | Αντισωματα κατα her3 και χρησεις αυτων | |
CY1120471T1 (el) | Αντισωματα κατα του cd70 | |
CY1119591T1 (el) | Πρωτεϊνες ειδικης συνδεσης και χρησεις αυτων | |
CY1117859T1 (el) | Αντισωματα και ανοσοσυζευγματα anti-cd79b και μεθοδοι χρησης | |
CY1117767T1 (el) | Rsv-ειδικα προσδενομενα μορια και μεσα για την παραγωγη αυτων | |
CY1115639T1 (el) | Διειδικα αγωνιστικα αντισωματα υποδοχεα θανατου | |
PE20151289A1 (es) | Anticuerpos que se unen al tl1a y sus usos | |
CY1119154T1 (el) | Anti-vla-4 αντισωματα | |
CY1116313T1 (el) | Αντισωματα εναντιον il-25 | |
CY1119890T1 (el) | Θεραπευτικη αγωγη ογκων χρησιμοποιωντας ειδικο αντισωμα αντι-l1 | |
EA201891446A1 (ru) | Молекулы полиспецифичных антител, имеющие специфичность к tnf-альфа, il-17a и il-17f | |
CY1122711T1 (el) | Μεθοδος για την ενεργοποιηση και τη συζευξη βιομοριων | |
CY1124445T1 (el) | Αντισωματα αντι-ccl17 |